Browsing by Author "Heymans, Stephane"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism
    (SpringerLink, 2021-02-09) Dufeys, Cécile; Daskalopoulos, Evangelos-Panagiotis; Castanares-Zapatero, Diego; Conway, Simon J.; Ginion, Audrey; Bouzin, Caroline; Ambroise, Jérôme; Bearzatto, Bertrand; Gala, Jean-Luc; Heymans, Stephane; Papageorgiou, Anna-Pia; Vinckier, Stefan; Cumps, Julien; Balligand, Jean-Luc; Vanhaverbeke, Maarten; Sinnaeve, Peter; Janssens, Stefan; Bertrand, Luc; Beauloye, Christophe; Horman, Sandrine; Pediatrics, School of Medicine
    We have previously demonstrated that systemic AMP-activated protein kinase α1 (AMPKα1) invalidation enhanced adverse LV remodelling by increasing fibroblast proliferation, while myodifferentiation and scar maturation were impaired. We thus hypothesised that fibroblastic AMPKα1 was a key signalling element in regulating fibrosis in the infarcted myocardium and an attractive target for therapeutic intervention. The present study investigates the effects of myofibroblast (MF)-specific deletion of AMPKα1 on left ventricular (LV) adaptation following myocardial infarction (MI), and the underlying molecular mechanisms. MF-restricted AMPKα1 conditional knockout (cKO) mice were subjected to permanent ligation of the left anterior descending coronary artery. cKO hearts exhibit exacerbated post-MI adverse LV remodelling and are characterised by exaggerated fibrotic response, compared to wild-type (WT) hearts. Cardiac fibroblast proliferation and MF content significantly increase in cKO infarcted hearts, coincident with a significant reduction of connexin 43 (Cx43) expression in MFs. Mechanistically, AMPKα1 influences Cx43 expression by both a transcriptional and a post-transcriptional mechanism involving miR-125b-5p. Collectively, our data demonstrate that MF-AMPKα1 functions as a master regulator of cardiac fibrosis and remodelling and might constitute a novel potential target for pharmacological anti-fibrotic applications.